Meyka AI API is live for developers.Start building.
Advertisement
Qiagen N.V.

Qiagen N.V. (QGEN) Stock Overview

Explore Qiagen N.V.’s financial performance, market position, analyst ratings, and future outlook.

QGENNYSE
HealthcareMedical - Diagnostics & Research
$36.68
$0.88(2.34%)
U.S. Market opens in 45h 14m
Advertisement

Qiagen N.V. (QGEN)

Meyka AI Score

Z

Key Financials

Market Cap7.6B
P/E Ratio18.82
EPS (TTM)$1.96
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 Month$44.90
3 Months$50.63
1 Year Target$49.23

QGEN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Qiagen N.V. (QGEN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 54.54, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $49.23.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 18.82 and a market capitalization of 7.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.37%
5-Day Change
0.14%
1-Month Change
7.85%
3-Month Change
-21.04%
6-Month Change
-22.00%
Year-to-Date (YTD) Change
-22.54%
1-Year Change
-19.51%
3-Year Change
-20.71%
5-Year Change
-22.80%
All-Time (Max) Change
1752.02%

Contact Information

31 77 355 6600
Hulsterweg 82, Venlo, NaN, 5912 PL

Company Facts

5,700 Employees
IPO DateJun 28, 1996
CountryUS
Actively Trading

Frequently Asked Questions